Abstract
Background
Ulcerative colitis (UC) is the large intestine disease that results in chronic inflammation and ulcers in the colon. Rg3-enriched Korean Red Ginseng extract (Rg3-RGE) is known for its pharmacological activities. Persicaria tinctoria (PT) is also used in the treatment of various inflammatory diseases. The aim of this study is to investigate the attenuating effects of Rg3-RGE with PT on oxazolone (OXA)-induced UC in mice.
Methods
A total of six groups of mice including control group, OXA (as model group, 1.5%) group, sulfasalazine (75 mg/kg) group, Rg3-RGE (20 mg/kg) group, PT (300 mg/kg) group, and Rg3-RGE (10 mg/kg) with PT (150 mg/kg) group. Data on the colon length, body weight, disease activity index (DAI), histological changes, nitric oxide (NO) assay, Real-time PCR of inflammatory factors, ELISA of inflammatory factors, Western blot, and flow cytometry analysis were obtained.
Results
Overall, the combination treatment of Rg3-RGE and PT significantly improved the colon length and body weight and decreased the DAI in mice compared with the treatment with OXA. Additionally, the histological injury was also reduced by the combination treatment. Moreover, the NO production level and inflammatory mediators and cytokines were significantly downregulated in the Rg3-RGE with the PT group compared with the model group. Also, NLR family pyrin domain containing 3 (NLRP3) inflammasome and nuclear factor kappa B (NF-κB) were suppressed in the combination treatment group compared with the OXA group. Furthermore, the number of immune cell subtypes of CD4+ T-helper cells, CD19+ B-cells, and CD4+ and CD25+ regulatory T-cells (Tregs) was improved in the Rg3-RGE with the PT group compared with the OXA group.
Conclusion
Overall, the mixture of Rg3-RGE and PT is an effective therapeutic treatment for UC.
Keywords: Korean Red Ginseng, Ginsenoside Rg3, Persicaria tinctoria, Inflammation, Colitis
Graphical abstract
1. Introduction
Ulcerative colitis (UC) is a type of chronic inflammatory disease that results in intestinal abnormalities, such as inflammation of the colonic mucosa, abdominal pain, and bloody diarrhea [[1], [2], [3]]. Loss of body weight and anemia are also common symptoms of UC [4,5]. Although the etiology of UC is unknown, it has been reported that the commonly considered risk factors for UC are the dysfunction of the immune system, environmental factors, lifestyle, Western diet, and family health history [5]. Without proper treatment, complications may occur, including colon dilation and colon cancer. Steroidal, non-steroidal, anti-inflammatory, and immune-suppressive drugs are commonly used in the treatment of UC [1,6]. However, prolonged treatment with these drugs results in complications and side effects. Hence, studies have focused on the use of herbal products as an alternative therapeutic method in addition to the modern treatment for UC.
Panax ginseng (family: Araliaceae) is an important alternative medicine. Since it induces numerous pharmacological activities, it is one of the widely used medicinal herbs worldwide, especially in Asia [2,5]. Over many years, studies have been conducted to identify various medicinal properties and active phytochemicals in ginseng. Panax ginseng is widely been reported to possess analgesic, anti-inflammatory, anti-oxidant, anti-ulcer, anti-cancer, immunosuppressive, anti-fungal, anti-hypertensive, anti-platelet, anti-thrombotic, anti-diabetic properties [[7], [8], [9]]. Ginsenosides are the active biological components of ginseng, and Rg3 is one of the important ginsenosides that have anti-inflammatory and anti-cancer properties [2]. Persicaria tinctoria (PT) (family: Polygonaceae) is also an important natural medicine and is traditionally used in the treatment of inflammation, fever, and edema [10]. It has also been reported that PT induces anti-oxidant and anti-inflammatory activities [2].
Previous studies have shown that an imbalance of immune cells, such as T-helper (Th) cells and regulatory T cells (Tregs), occurs during the pathogenesis of UC [2,6]. Oxazolone (OXA) was used as the colitis model inducer agent due to the similarities between human UC and OXA-mediated UC [6,11]. OXA induces several intracellular signaling pathways [6]. NLR family pyrin domain containing 3 (NLRP3) inflammasomes, and nuclear factor-kappa B (NF-κB) are responsible for the overproduction of inflammatory mediators and cytokines, such as cyclooxygenase (COX-2), inducible nitric oxide synthase (iNOS), interleukin-1β (IL-1β), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-13 (IL-13) and tumor necrosis factor-a (TNF-α) [[12], [13], [14]].
There is no study to reveal restorative properties of the mixture of Korean Red Ginseng extract (Rg3-RGE) with PT on OXA-induced UC in mice. Therefore, this study investigated the inhibiting properties of Rg3-RGE and PT extracts in OXA-induced UC in mice. Herein, we hypothesized that Rg3-RGE and PT potentially suppressed OXA-induced UC, suggesting that the mixture treatment of Rg3-RGE with PT can be used in addition to the modern treatment for UC.
2. Materials and methods
2.1. Chemicals and reagents
The oxazolone and sulfasalazine were purchased Sigma-Aldrich (St. Louis, MA, USA). Primary antibodies for western blot including phosphorylated (p)–NF–κB (Catalog No. 3033), and NLRP3 (Catalog No. 15101), and horseradish peroxidase-linked secondary antibody (Catalog No. 7074) were purchased Cell Signaling Technology (Danvers, MA, USA). The conjugated fluorescence antibodies for flow cytometry analysis (FACS) including PE-Cy5 anti-CD3, PE anti-CD4, fluorescein isothiocyanate (FITC) anti-CD8, FITC anti-CD19, and FITC anti-CD25, were obtained BD Biosciences (San Diego, CA, USA). All other chemicals and reagents were obtained from Sigma Aldrich.
2.2. Sample preparation
Red ginseng was obtained from Korea Ginseng Corporation (Daejeon, Republic of Korea). Briefly, the Rg3-RGE used in this study was made by extracting 25:75 red ginseng root/stem with distilled water and then adding 55% ethanol. The extract was then subjected to a high-performance liquid chromatography system (HPLC) according to our previous studies [15,16]. The resulting constituent profile is shown in Table S1. In addition, Persicaria tinctorial (PT) was made by boiling the plant's leaves in 70% ethanol, condensing the extract, and lyophilizing the powdered form.
2.3. Animals and treatment
6–8-week-old and C57BL/6 male mice (18–23 g) were used in this study. Animals were kept in a pathogen-free environment and Food and water were given ad libitum. They were divided into six groups (n = 6/group) according to treatment: (1) control; (2) 1.5% OXA; (3) sulfasalazine (75 mg/kg) + OXA (positive control); (4) Rg3-RGE (20 mg/kg) + OXA; (5) PT (300 mg/kg) + OXA; and (6) combination of Rg3-RGE (10 mg/kg) and PT (150 mg/kg) + OXA. All non-control groups were orally administered OXA (1.5%) with drinking water for 7 days. Oral administration of Rg3-RGE, PT, combination of Rg3-RGE with PT and sulfasalazine were performed together on the same day as the administration of OXA. Animal were anesthetized, blood, and tissues (colon and spleen) were collected for the further experiment on the 7th day. All animal experiment procedures were followed the Institutional Animal Care and Use Committee's guidelines (IACUC). The animal experiment protocol was approved by Kyungpook National University's Institutional Animal Use and Care Committee in Daegu, Republic of Korea. (approval number-KNU2018-002).
2.4. Assessment of colon tissues and disease activity index (DAI)
Animal were sacrificed, and their colon tissues were removed. The length of colon tissues was measured by the scale. Body weight was measured daily for 7 days of the experiment period. The mice were observed general disposition, stool consistency, and presence of blood in stools. Using the disease activity index (DAI) scoring system, combined body score, stool consistency, and bloody stools were determined according to the previous study [2,6].
2.5. Histological analysis
The colon tissues of mice were removed and harvested in the 10% formalin and routinely processed in a graded ethanol series and toluene. For histological analysis, the colon tissues were embedded in paraffin and then 5-μm-thick slices were cut. The sections of tissues were stained with hematoxylin and eosin (H&E) according to previous method [17,18]. The stained samples were observed using a light microscope.
2.6. Nitric oxide (NO) assay
Nitric oxide was determined using the Griess reaction assay method as described previously [19]. Briefly, the supernatant was collected and added with the equal volume of Griess reagent (reagent A and reagent B) for the determination of nitric oxide (NO). Samples were measured using a microplate reader at 540 nm absorbance (Molecular Devices, San Jose, CA, USA).
2.7. Quantitative real-time polymerase chain reaction (qRT-PCR)
The colon tissues were used and qRT-PCR reactions were carried out using CFX96 (Bio-Rad, Hercules, CA, USA). Briefly, the total RNA was extracted from colon tissues using Trizol reagent and reverse transcribed using a cDNA kit (Bioneer, Daejeon, Republic of Korea) as previously described [20]. The cDNA underwent a qRT-PCR). GAPDH was used as a loading control gene. The qRT-PCR primer sequences are given to Table 1.
Table 1.
Real-Time Polymerase Chain Reaction Primer Used in This Study
| Primer | Forward primer sequences (5′-3′) | Reverse primer sequences (5′-3′) |
|---|---|---|
| iNOS | GGCAGCCTGTGAGACCTTTG | GCATTGGAAGTGAAGCGTTTC |
| COX-2 | GGCAGCCTGTGAGACCTTTG | GCATTGGAAGTGAAGCGTTTC |
| IL-1β | CAACCAACAAGTGATATTCTCCATG | GATCCACACTCTCCAGCTGCA |
| IL-5 | GAAGTGTGGCGAGGAGAGAC | GCACAGTTTTGTGGGGTTTT |
| IL-6 | TCCAGTTGCCTTCTTGGGAC | GTGTAATTAAGCCTCCGACTTG |
| IL-13 | AGCATGGTATGGAGTGTGGA | TTGCAATTGGAGATGTTGGT |
| TNF-α | TGCCTATGTCTCAGCCTCTTC | GAGGCCATTTGGGAACTTCT |
| NLRP3 | TGCTCTTCACTGCTATCAAGCCCT | ACAAGCCTTTGCTCCAGACCCTAT |
| GAPDH | CACTCACGGCAAATTCAACGGCAC | GACTCCACGACATACTCAGCAC |
2.8. Enzyme-linked immunosorbent assay (ELISA)
TNF-α, IL-1β, IL-5, and IL-13 levels in the plasma of oxazolone-induced colitis mice were measured as described previously [21] using mouse TNF-α, mouse IL-1β, mouse IL-5, and mouse IL-13. ELISA kits were used according to the manufacturer's protocols (R&D Systems, Minneapolis, MN, USA). Samples were analyzed with three independent experiments.
2.9. Western blot analysis
Western blot was performed with modifications, as described previously [19,20]. Briefly, the proteins were extracted from the colon tissues, concentrations were measured, and samples were prepared in sodium dodecyl sulfate and boiled for 5 min. The samples were separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins were transferred to the poly vinylidene fluoride membranes, blocked with skim milk (5%) for 1 h at room temperature. Membranes were washed with tris-buffered saline with tween (TBST) (washing buffer) three times/each 10 min. Membranes were incubated with the p–NF–κB (Catalog No. 3033) and NLRP3 (Catalog No. 15101) primary antibodies (1:1000) overnight at 4°C. Furthermore, the membranes were washed with TBST (washing buffer) three times/each 10 min. and were incubated with HRP-labeled secondary antibodies (1:3000) for 1 h and again washed with TBST three times/each 10 min. The protein bands were detected using enhanced chemiluminescence solution (1/1 ratio) in Imager ALS 500 (General Electrics, Boston, MA, USA).
2.10. Fluorescence-activated cell sorting (FACS) analysis
Briefly, mice were sacrificed and the spleen tissues were isolated and pulverized lightly using a syringe plunger. Then spleen tissues were passed through a cell strainer (70 μm) into the phosphate-buffered saline (PBS) and centrifuged at 245 g, 5 min at 25 °C. In addition, red blood cells (RBCs) were lysed and then centrifuged to get splenocytes. The splenocytes (1 × 105) were stained with specific antibodies. Cells were resuspended in 2% FBS in phosphate-buffered saline (FACS buffer). Finally, samples were analyzed using BD FACSAria III™ (BD Biosciences, San Jose, CA, USA).
2.11. Statistical analysis
Data are represented as mean and standard error of mean (SEM). The statistical significance was analyzed by One-way analysis of variance (ANOVA). The statistical analyses with a ∗∗∗p of <0.001, ∗∗p of <0.05, and ∗p of <0.01 were considered significant when compared to the OXA group, and ###p of <0.001 when compared to the control group.
3. Results
3.1. Effects of Rg3-enriched Korean Red Ginseng extract with Persicaria tinctoria on oxazolone-induced ulcerative colitis
The aim of this study is to investigate the preventive effects of Rg3-RGE and PT on OXA-induced UC using a mice model. The mice were treated for 7 days with the extracts of Rg3-RGE and PT alone as well as their combination treatment with the sulfasalazine being a positive control. Compared to the control, the OXA group had a remarkably lower colon length, which showed the establishment of colitis. In the Rg3-RGE with PT group, the colon length was retained similar to the sulfasalazine group (Fig. 1A and B). As expected, the body weight was markedly decreased in the OXA group compared to control group, and the body weight significantly recovered with the treatment of Rg3-RGE with PT (Fig. 1C).
Fig. 1.
Effects of Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria on mice with oxazolone (OXA)-induced ulcerative colitis. (A) Gross observation of the colon tissues in different groups. (B) Measurement of colon length. (C) Mean body weight over 7 days. (D) Disease activity index of experimental mice. Data are presented as mean ± standard error of the mean (SEM) of n = 6 mice/each group. ###p < 0.001, compared with the control group; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, compared with the OXA group; ∗∗∗+p < 0.001, compared with the Rg3-RGE and P.T independently.
Moreover, the DAI was markedly higher in the OXA-induced UC group compared to the control, and the DAI was significantly lesser in the Rg3-RGE with PT group than that in the alone treatment (Rg3-RGE or PT) (Fig. 1D). These results suggesting that the combine treatment of Rg3-RGE with PT surprisingly reduced the degree of UC in mice.
3.2. Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria prevented oxazolone-induced ulcerative colitis
To further investigate the histological changes, H&E staining was analyzed (Fig. 2A and B), and the pathological scores were calculated in accordance with the study of Geboes et al [22]. In control group, the basic colon structure was normal, and the mucosa, submucosa, serosa, muscle, and crypt of the colon tissues were intact. Moreover, no infiltrated inflammatory cells were observed in the layers of the colon tissues. However, damage in the structures of the colon tissues, complete loss of crypt and epithelial cell integrity, and inflammatory cell infiltration were clearly observed in the OXA group. After the treatment with the Rg3-RGE and PT alone and their combined treatment, the OXA-induced injury was significantly relieved. Interestingly, a better therapeutic effect was observed in the combination treatment of Rg3-RGE and PT. Hence, the combination treatment of Rg3-RGE (10 mg/kg) and PT (150 mg/kg) was better for the prevention of OXA-induced injuries.
Fig. 2.
Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria prevented oxazolone (OXA)-induced ulcerative colitis. (A) Colon tissues were stained with hematoxylin and eosin to detect morphological changes. (B) Pathological score for colon damage. Data are presented as mean ± standard error of the mean (SEM) of n = 6 mice/each group. ###p < 0.001, compared with the control group; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, compared with the OXA group; ∗∗∗+p < 0.001, compared with the Rg3-RGE and P.T independently.
3.3. Effects of Rg3-enriched Korean Red Ginseng extract with Persicaria tinctoria on inflammatory cytokine production in oxazolone-induced ulcerative colitis
Next, we aimed to investigate the induction of NO and mRNA expression of pro-inflammatory mediators and cytokines (Fig. 3A–C). The NO induction is remarkably higher in the OXA group, in comparing with control. However, sulfasalazine and the combination treatment of Rg3-RGE and PT significantly suppressed the NO production compared with OXA-induced UC.
Fig. 3.
Effects of Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria on the nitric oxide (NO) and pro-inflammatory cytokines production in oxazolone (OXA)-induced ulcerative colitis in mice. (A) NO production was analyzed in the plasma. (B) Expression of the pro-inflammatory mediators (e.g., iNOS and COX2) and cytokines (e.g., IL-1β, IL-6 and the TNF-α mRNA levels were analyzed. (C) Expression of the pro-inflammatory cytokines (e.g., IL-5 and IL-13) and NLRP3 mRNA levels were analyzed. Data are presented as mean ± standard error of the mean (SEM) of n = 6 mice/each group. ###p < 0.001, compared with the control group; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, compared with the OXA group; ∗∗∗+p < 0.001, compared with the Rg3-RGE and P.T independently.
The mRNA expression levels of inflammatory factors, including inducible COX-2, iNOS, IL-6, TNF-α, IL-1β, IL-5, IL-13, and NLRP3, were determined. In the sulfasalazine group and the Rg3-RGE (10 mg/kg) and PT (150 mg/kg) group, marked inhibition of COX-2, iNOS, TNF-α, IL-1β, IL-6, IL-5, IL-13, and NLRP3 was observed (Fig. 3A and B). On the other hand, the OXA-induced UC group showed a significant upregulation of iNOS, COX-2, TNF-α, IL-1β, IL-5, IL-6, IL-13, and NLRP3 compared with the control group. Furthermore, the results indicated that Rg3-RGE and PT have potent anti-inflammatory effects in the treatment of UC.
3.4. Effects of Rg3-enriched Korean Red Ginseng extract with Persicaria tinctoria on signaling pathway in oxazolone-induced ulcerative colitis
To elaborate on the mechanism of signaling pathways and protein expression levels in OXA-induced UC, the ELISA was used to confirm the protein expression levels of pro-inflammatory factors such as TNF-α, IL-1β, IL-5, and IL-13 (Fig. 4A–D). The pro-inflammatory cytokine levels markedly increased in the OXA group compared with the control group. The contents of TNF-α, IL-1β, IL-5, and IL-13 were remarkably reduced in the positive control (sulfasalazine) group and Rg3-RGE with the PT group compared with the OXA group.
Fig. 4.
Effects of Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria on oxazolone (OXA)-induced inflammation in mice. (A–D) Pro-inflammatory cytokines levels determined in the plasma using ELISA. (E) Protein levels of the NLR family pyrin domain containing 3 (NLRP3), nuclear factor-κB and β-actin used as loading control were analyzed in the colon tissues via western blot analysis. Data are presented as mean ± standard error of the mean (SEM) of n = 6 mice/each group. ###p < 0.001, compared with the control group; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, compared with the OXA group; ∗∗∗+p < 0.001, compared with the Rg3-RGE and P.T independently.
The signaling pathway of Rg3-RGE and PT in the downregulation of the OXA-induced UC was investigated using Western blot analysis (Fig. 4E). NF-κB is the key regulator of pro-inflammatory mediators and cytokine production. Protein expression of NLRP3 and phosphorylated NF-κB (p–NF–κB) in the OXA group was significantly overexpressed compared with the control group. However, the sulfasalazine and Rg3-RGE with PT groups significantly suppressed the activation of NLRP3 and NF-κB, which indicated that the treatment with Rg3-RGE and PT had targeted the NF-κB signaling pathway reversing the OXA-induced inflammation.
3.5. Effects of Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria on immune cell subtype regulation in spleen
To justify the imbalance in the immune system, we determined the immune cell subtypes using an OXA-induced colitis model (Fig. 5A–C). In the OXA group, CD4+ T-cells, CD8 T-cells, CD19 B-cells, and regulatory T-cells (CD4+-CD25+ Tregs cells) were reduced compared to the control group. Similar results were observed in our previous study [2]. However, treatment with the positive control (sulfasalazine) and the combination treatment of Rg3-RGE with PT significantly increased the T-cells (CD4+), B-cells (CD19), and regulatory T-cells. The trend of CD8 cytotoxic T-cells was higher in the Rg3-RGE with the PT group but not markedly compared to the OXA group. The FACS results indicated that combination treatment of Rg3-RGE with PT modulated the immune system in inflammation and UC.
Fig. 5.
Effects of Rg3-enriched Korean Red Ginseng extract and Persicaria tinctoria on the immune cells in the mice. (A) Percentage of the CD4+ T-cells and CD8+ cytotoxic T-cells were analyzed via fluorescence-activated cell sorting in the spleen tissues. (B) Percentage of the CD19+ B-cells. (C) CD4+ and CD25+ regulatory T-cells (Tregs) in the spleen. Data are presented as mean ± standard error of the mean (SEM) of n = 6 mice/each group. #p < 0.05, compared with the control group; ∗p < 0.05, compared with the OXA group.
4. Discussion
In the present study, oxazolone (OXA) was used to induce ulcerative colitis (UC) as the symptomatical and histopathological characteristics, which are similar between OXA-induced UC in mice and human UC. Previous studies have shown that the dextran sulfate sodium (DSS)-induced UC model is also extensively used to evaluate the effects of the medicinal plant extract, single compounds, and different drugs on UC [2,23,24]. Our group have shown that protective activity of Rg3-RGE and PT and their mixture on DSS-induced UC mice [2]. Here, we confirmed and demonstrated the alleviating property of Rg3-RGE with PT by using UC inducer such as OXA. Although, DSS-stimulated colitis is the common and extensively used method for colitis study but to elucidate and more confirm the reducing effect of Rg3-RGE with PT in UC, we used OXA to induce colitis model.
In our study, UC induced by the administration of 1.5 % OXA with drinking water in mice for 7 days and observed by the destruction of the mucosa in the colon tissues and inflammatory cells infiltration in the mucosa and muscle layer. Previous studies also showed that oxazolone-induced damage in the colon structure and inflammatory cell infiltration in the mucosa [6,25]. Although a number of colitis models have been proposed, OXA-induced colitis in mice provides a new approach to assess the potency of the various therapeutic methods for UC.
A common treatment in mild to moderate UC, including steroidal and non-steroidal anti-inflammatory drugs and targeted drugs, depends on the inflammation and severity of the UC [6]. Sulfasalazine as a positive control drug was selected based on the previously reported significant therapeutic effects on UC [6,26,27].
Inflammatory process is the key inhibitory biological response to harmful stimuli, which including infections and tissue injuries [19,20,28]. Previous studies have shown that inflammatory cells are activated in DSS- and OXA-induced UC and lead to the overproduction of pro-inflammatory cytokines [6]. Uncontrolled excessive expressions of pro-inflammatory cytokines are responsible for many chronic diseases, such as UC. In this study, we revealed that the oral administration of Rg3-RGE and PT attenuated OXA-induced UC.
It has been stated that IL-1β increases the expression of COX-2 and iNOS, which modulate the synthesis of NO and prostaglandin E2. Nuclear factor-κB (NF-κB) controls the inflammatory response by inducing other cytokines, such as IL-6, to be produced. Moreover, the NLRP3 inflammasome is also a known source of inflammation [2,13,14]. In the present study, Rg3-RGE, PT, and their combined treatment significantly downregulated the NO production and COX-2, iNOS, IL-6, TNF-α, IL-1β, IL-5, IL-13, and NLRP3 mRNA levels in UC mice. Our data are reliable with the previous study where it was indicated that UC was mediated by IL-13 [29].
Rg3-RGE and PT markedly reduced the protein levels of TNF-α, IL-1β, IL-5, and IL-13 in plasma. Interestingly, the combination treatment of Rg3-RGE and PT exhibited significant inhibitory effects compared with the individual treatment of Rg3-RGE or PT. OXA-induced UC promotes the overexpression of pro-inflammatory cytokines [30,31]. However, the treatment with Rg3-RGE and PT suppressed the OXA-induced pro-inflammatory cytokines. These results suggest that Rg3-RGE and PT have potent anti-inflammatory properties.
This study showed that Rg3-RGE has significantly reduced the pro-inflammatory cytokines and inhibited the NF-kB signaling pathway involved in inflammatory responses [15,16]. Various chemical agents activate the NF-κB signaling pathway and promote the phosphorylation of NF-kB, resulting in the nuclear translocation of active NF-κB [[32], [33], [34]]. This phenomenon induces the transcription of pro-inflammatory factors.
The results indicate that Rg3-RGE and PT inhibited the OXA-induced phosphorylation of NF-κB in UC mice. It has been reported that DSS-induced UC was suppressed by NF-κB and NLRP3 inflammasome activation [35,36]. The results of the western blot analysis indicated that Rg3-RGE and PT reversed the OXA-induced upregulation of NLRP3. Our data confirm that the suppression of the NF-κB pathway and inhibition of NLRP3 is involved in the anti-inflammatory properties of Rg3-RGE and PT in the UC model.
Previously, our group has shown that the number of subtypes of immune cells was modulated in the DSS-induced UC mice [2]. The results indicated that the treatment with Rg3-RGE and PT increased the immune cell subtypes, including CD4+ Th cells, CD19+ B-cells, and CD4+ and CD25+ regulatory T cells in the spleen tissues (Fig. 5A–C). It was reported that OXA-induced UC was alleviated through Th2/Th17 suppression and Treg induction [37]. Furthermore, the current study showed that Rg3-RGE and PT inhibited the pro-inflammatory cytokines production and upregulated the number of immune cell subtypes in OXA-induced UC.
5. Conclusion
Overall, Rg3-RGE, PT, and their combined treatment protected the mice against OXA-induced inflammation and colon injuries. The preventive effects may be mediated through the inhibition of the NF-κB pathway and reduced by NLRP3. The Rg3-RGE with PT inhibited the production of pro-inflammatory factors in the OXA-induced UC mice. Moreover, the combined treatment with Rg3-RGE and PT improved the OXA-induced macroscopic parameters, such as colon tissue length, loss of body weight, and DAI, and reduced histological colon tissue injuries. The treatment with Rg3-RGE and PT also modulated the CD4+ T-cells, CD19+ B-cells, and CD25+ regulatory T-cells in OXA-induced UC mice. However, it is important to investigate the therapeutic potency of Rg3-RGE and PT in a clinical trial.
Data availability
All data are analysed during this study and added with this manuscript.
Funding
This work was financially supported by the Korean Society of Ginseng (2018) and the National Research Foundation of Korea (2022R1A2C1012963).
Declaration of competing interest
All authors declare that they have no conflict of interest.
Acknowledgements
We are grateful to Professor Man Hee Rhee for his continuous supervision and support. We are thankful to Evelyn Saba for the experiments and H M Arif Ullah for the manuscript writing and final review and editing. Also, we would like to thank Yuan Yee Lee, Sung Dae kim, Seong-Bok Hong, Sun-Hee Hyun, Yi-Seong kwak, Chae-Kyu Park for technical help.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jgr.2021.07.001.
Appendix A. Supplementary data
The following is the supplementary data to this article:
References
- 1.Feuerstein J.D., Cheifetz A.S. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clinic Proceedings. 2014;89(11):1553–1563. doi: 10.1016/j.mayocp.2014.07.002. [DOI] [PubMed] [Google Scholar]
- 2.Saba E., Lee Y.Y., Rhee M.H., Kim S.-D. Alleviation of ulcerative colitis potentially through th1/th2 cytokine balance by a mixture of Rg3-enriched Korean red ginseng extract and Persicaria tinctoria. Molecules. 2020;25(22):5230. doi: 10.3390/molecules25225230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lin W.C., Chang C.W., Chen M.J., Chu C.H., Shih S.C., Hsu T.C., Wang H.Y. Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis. PloS One. 2017;12(12) doi: 10.1371/journal.pone.0189377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gajendran M., Loganathan P., Jimenez G., Catinella A.P., Ng N., Umapathy C., Ziade N., Hashash J.G. A comprehensive review and update on ulcerative colitis. Disease-a-month. 2019;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. [DOI] [PubMed] [Google Scholar]
- 5.Saba E., Lee Y.Y., Kim M., Hyun S.H., Park C.K., Son E., Kim D.S., Kim S.D., Rhee M.H. A novel herbal formulation consisting of red ginseng extract and Epimedium koreanum Nakai-attenuated dextran sulfate sodium-induced colitis in mice. Journal of Ginseng Research. 2020;44(6):833–842. doi: 10.1016/j.jgr.2020.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhang L., Cao N., Wang Y., Wang Y., Wu C., Cheng X., Wang C. Improvement of oxazolone-induced ulcerative colitis in rats using andrographolide. Molecules. 2020;25(1):76. doi: 10.3390/molecules25010076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li Z., Ji G.E. Ginseng and obesity. Journal of Ginseng Research. 2018;42(1):1–8. doi: 10.1016/j.jgr.2016.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kim J.Y., Park J.Y., Kang H.J., Kim O.Y., Lee J.H. Beneficial effects of Korean red ginseng on lymphocyte DNA damage, antioxidant enzyme activity, and LDL oxidation in healthy participants: a randomized, double-blind, placebo-controlled trial. Nutr J. 2012;11(1):1–9. doi: 10.1186/1475-2891-11-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Park J.G., Son Y.-J., Aravinthan A., Kim J.-H., Cho J.Y. Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells. Journal of Ginseng Research. 2016;40(4):431–436. doi: 10.1016/j.jgr.2016.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kim S.-J., Jang T.W., Kim D.-W., Park J.H. Study on antioxidant and anti-inflammatory activities of Persicaria tinctoria. The Korea Journal of Herbology. 2015;30(6):17–24. [Google Scholar]
- 11.Randhawa P.K., Singh K., Singh N., Jaggi A.S. A review on chemical-induced inflammatory bowel disease models in rodents. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2014;18(4):279. doi: 10.4196/kjpp.2014.18.4.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gao Z., Yu C., Liang H., Wang X., Liu Y., Li X., ji K., Xu H., Yang M., Liu K. Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: involvement of NF-κB and MAPK signalling pathways. Int Immunopharmacol. 2018;57:82–90. doi: 10.1016/j.intimp.2018.02.012. [DOI] [PubMed] [Google Scholar]
- 13.Zhou W., Liu X., Zhang X., Tang J., Li Z., Wang Q., Hu R. Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. Oncotarget. 2017;8(35):58903. doi: 10.18632/oncotarget.19440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bauer C., Duewell P., Mayer C., Lehr H.A., Fitzgerald K.A., Dauer M., Tschopp J., Endres S., Latz E., Schnurr M. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59(9):1192–1199. doi: 10.1136/gut.2009.197822. [DOI] [PubMed] [Google Scholar]
- 15.Saba E., Irfan M., Jeong D., Ameer K., Lee Y.Y., Park C.K., Hong S.B., Rhee M.H. Mediation of antiinflammatory effects of Rg3-enriched red ginseng extract from Korean Red Ginseng via retinoid X receptor α-peroxisome-proliferating receptor γ nuclear receptors. Journal of Ginseng Research. 2019;43(3):442–451. doi: 10.1016/j.jgr.2018.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Saba E., Jeong D., Irfan M., Lee Y.Y., Park S.J., Park C.K., Rhee M.H. Anti-inflammatory activity of Rg3-enriched Korean red ginseng extract in murine model of sepsis. Evidence-based complementary and alternative medicine. eCAM. 2018;2018:6874692. doi: 10.1155/2018/6874692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ullah H., Elfadl A., Park S., Chung M.-J., Son J.-Y., Yun H.-H., Park J.M., Yim J.H., Jung S.J., Park J.K. Renal failure in a female muskrat. Journal of Life Science. 2020;30(7):630–633. [Google Scholar]
- 18.Elfadl A.K., Park S., Ullah H., Youn S.-H., Chung M.-J., Son J.-Y., Lee J.Y., Lee S.W., Lee A.R., Baek S.M. Sertoli cell tumor (SCT) in a captive black bear (Ursus americanus) Veterinary Sciences. 2019;6(4):77. doi: 10.3390/vetsci6040077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ullah H.M.A., Lee Y.Y., Kim S.D., Rhee M.H. Duchesnea indica extract attenuates coal fly ash-induced inflammation in murine alveolar macrophages through the NF-kappa B pathway. Evidence-Based Complementary and Alternative Medicine. 2021;2021:5546052. doi: 10.1155/2021/5546052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ullah H., Elfadl A., Park S., Kim Y.D., Chung M.-J., Son J.-Y., Yun H.H., park J.M., Yim J.H., Jung S.J. Nogo-A is critical for pro-inflammatory gene regulation in myocytes and macrophages. Cells. 2021;10(2):282. doi: 10.3390/cells10020282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee Y.Y., Yang W.K., Han J.E., Kwak D., Kim T.H., Saba E., Kim K.D., Lee Y.C., Kim J.S., Kim S.H. Hypericum ascyron L. extract reduces particulate matter-induced airway inflammation in mice. Phytotherapy Research : PTR. 2021;35(3):1621–1633. doi: 10.1002/ptr.6929. [DOI] [PubMed] [Google Scholar]
- 22.Geboes K., Riddell R., Öst A., Jensfelt B., Persson T., Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47(3):404–409. doi: 10.1136/gut.47.3.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chassaing B., Aitken J.D., Malleshappa M., Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104(1):15–25. doi: 10.1002/0471142735.im1525s104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702. doi: 10.1016/0016-5085(90)90290-h. [DOI] [PubMed] [Google Scholar]
- 25.Kojima R., Kuroda S., Ohkishi T., Nakamaru K., Hatakeyama S. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. Journal of Pharmacological Sciences. 2004;96(3):307–313. doi: 10.1254/jphs.fp0040214. [DOI] [PubMed] [Google Scholar]
- 26.Gao W., Wang C., Yu L., Sheng T., Wu Z., Wang X., Zhang D., Lin Y., Gong Y. Chlorogenic acid attenuates dextran sodium sulfate-induced ulcerative colitis in mice through MAPK/ERK/JNK pathway. BioMed Research International. 2019;2019:6769789. doi: 10.1155/2019/6769789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Huang Y.-F., Zhou J.-T., Qu C., Dou Y.-X., Huang Q.-H., Lin Z.-X., Xian Y.F., Xie J.H., Xie Y.L., Lai X.P. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice. J Ethnopharmacol. 2017;198:389–398. doi: 10.1016/j.jep.2017.01.042. [DOI] [PubMed] [Google Scholar]
- 28.Ullah H.A., Zaman S., Juhara F., Akter L., Tareq S.M., Masum E.H., Bhattacharjee R. Evaluation of antinociceptive, in-vivo & in-vitro anti-inflammatory activity of ethanolic extract of Curcuma zedoaria rhizome. BMC Complement Altern Med. 2014;14(1):346. doi: 10.1186/1472-6882-14-346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002;17(5):629–638. doi: 10.1016/s1074-7613(02)00453-3. [DOI] [PubMed] [Google Scholar]
- 30.Wang X., Fan F., Cao Q. Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption. Molecular Medicine Reports. 2016;14(2):1173–1179. doi: 10.3892/mmr.2016.5358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Boirivant M., Fuss I.J., Chu A., Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. The Journal of Experimental Medicine. 1998;188(10):1929–1939. doi: 10.1084/jem.188.10.1929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhu G., Xin X., Liu Y., Huang Y., Li K., Wu C. Geraniin attenuates LPS-induced acute lung injury via inhibiting NF-κB and activating Nrf2 signaling pathways. Oncotarget. 2017;8(14):22835. doi: 10.18632/oncotarget.15227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhang Y., Xu T., Pan Z., Ge X., Sun C., Lu C., Chen H., Xiao Z., Zhang B., Dai Y. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury. Br J Pharmacol. 2018;175(5):840–854. doi: 10.1111/bph.14129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lin Y., Zhang M., Lu Q., Xie J., Wu J., Chen C. A novel chalcone derivative exerts anti-inflammatory and anti-oxidant effects after acute lung injury. Aging (Albany N Y) 2019;11(18):7805. doi: 10.18632/aging.102288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Liu W., Guo W., Hang N., Yang Y., Wu X., Shen Y., Cao J., Sun Y., Xu Q. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation. Oncotarget. 2016;7(21):30536. doi: 10.18632/oncotarget.8867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sun Y., Zhao Y., Yao J., Zhao L., Wu Z., Wang Y., Pan D., Miao H., Guo Q., Lu N. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation. Biochem Pharmacol. 2015;94(2):142–154. doi: 10.1016/j.bcp.2015.02.002. [DOI] [PubMed] [Google Scholar]
- 37.Huang Z., Jiang Y., Yang Y., Shao J., Sun X., Chen J., Dong L., Zhan J. 3, 3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. Molecular Immunology. 2013;53(4):335–344. doi: 10.1016/j.molimm.2012.09.007. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are analysed during this study and added with this manuscript.






